Vasodilator side effects · women undergoing fertility treatment
Vasodilator probably leads to higher vasodilator side effects compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Live birth · women undergoing fertility treatment
Vasodilator showed no clear difference in live birth compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Clinical pregnancy · women undergoing fertility treatment
Vasodilator may leads to higher clinical pregnancy compared with placebo or no treatment (low certainty).
1 finding from 1 review
Thickened endometrium · women undergoing fertility treatment
1 finding from 1 review
Multiple gestation or birth · women undergoing fertility treatment
Vasodilator showed no clear difference in multiple gestation or birth compared with placebo or no treatment (low certainty).
1 finding from 1 review
Miscarriage · women undergoing fertility treatment
Vasodilator showed no clear difference in spontaneous miscarriage compared with placebo or no treatment (low certainty).
1 finding from 1 review
Ectopic pregnancy · women undergoing fertility treatment
Vasodilator showed no clear difference in ectopic pregnancy compared with placebo or no treatment (low certainty).
1 finding from 1 review
Intervention not reported
Aldosterone antagonists plus loop diuretics plus systemic vasoconstrictors plus systemic vasodilator (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics plus systemic… (very low certainty).
1 finding from 1 review
HR 0.61 [0.02, 9.17]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus loop diuretics plus systemic vasodilator (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics plus systemic… (very low certainty).
1 finding from 1 review
HR 0.62 [0.03, 9.1]
Studies not reported
Very low
Migraine frequency Number of attacks · primary Raynaud's phenomenon
1 finding from 1 review
QoL · primary Raynaud's phenomenon
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (4 weeks' to 180 days' · primary Raynaud's phenomenon
1 finding from 1 review
RCS · primary Raynaud's phenomenon
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Migraine frequency Number of attacks · primary Raynaud's phenomenon
1 finding from 1 review
Severity of attacks · primary Raynaud's phenomenon
1 finding from 1 review
Duration of attacks · primary Raynaud's phenomenon
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · primary Raynaud's phenomenon
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (6 weeks' · primary Raynaud's phenomenon
Prostagladin/prostacyclin analogues may leads to higher adverse events (6 weeks' compared with placebo (low certainty).
1 finding from 1 review
RCS · primary Raynaud's phenomenon
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Frequency of attacks Per week (over 2 weeks) · primary Raynaud's phenomenon
1 finding from 1 review
no estimate extracted
1 study · 6 participants
Very low